Works by Reitsam, Nic G.

Results: 16

C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy of Multiple Myeloma Using [99mTc]Tc-PentixaTec.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 163, doi. 10.2967/jnumed.123.266305

By:

Enke, Johanna S.;
Reitsam, Nic G.;
Grosser, Bianca;
Kircher, Malte;
Dierks, Alexander;
Bundschuh, Ralph A.;
Wienand, Georgine;
Uhrmacher, Luise;
Trepel, Martin;
Schottelius, Margret;
Lapa, Constantin;
Pfob, Christian H.

Publication type:

Article

Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid Carcinoma.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 2001, doi. 10.2967/jnumed.123.265639

By:

Enke, Johanna S.;
Bundschuh, Ralph A.;
Wienand, Georgine;
Reitsam, Nic G.;
Kircher, Malte;
Pfob, Christian H.;
Lapa, Constantin;
Dierks, Alexander

Publication type:

Article

SARIFA – ein neuer entitätenübergreifender Biomarker.

Published in:

Die Pathologie, 2024, v. 45, n. 6, p. 397, doi. 10.1007/s00292-024-01368-9

By:

Grosser, Bianca;
Reitsam, Nic G.;
Grochowski, Przmyslaw;
Rentschler, Lukas;
Enke, Johanna;
Märkl, Bruno

Publication type:

Article

Granulomatous dermatitis: a rare pitfall in lymphoma staging with [18F]FDG-PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 11, p. 3479, doi. 10.1007/s00259-023-06284-3

By:

Enke, Johanna S.;
Gäble, Alexander;
Reitsam, Nic G.;
Schaller, Tina;
Trepel, Martin;
Hirschbühl, Klaus;
Welzel, Julia;
Dierks, Alexander;
Kircher, Malte;
Lapa, Constantin

Publication type:

Article

Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3151, doi. 10.1007/s00259-023-06237-w

By:

Enke, Johanna S.;
Reitsam, Nic G.;
Schaller, Tina;
Claus, Rainer;
Lapa, Constantin;
Dierks, Alexander

Publication type:

Article

Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 2, p. 245, doi. 10.2967/jnumed.124.268513

By:

Enke, Johanna S.;
Reitsam, Nic G.;
Dintner, Sebastian;
Liesche-Starnecker, Friederike;
Schaller, Tina;
Decker, Josua A.;
Langer, Angela;
Sipos, Eva;
Antic Nikolic, Ana;
Kröncke, Thomas;
Trepel, Martin;
Lapa, Constantin;
Claus, Rainer;
Märkl, Bruno;
Bundschuh, Ralph A.

Publication type:

Article

C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1640, doi. 10.2967/jnumed.124.268169

By:

Enke, Johanna S.;
Ritzel, Kathrin;
Asbach, Evelyn;
Reitsam, Nic G.;
Märkl, Bruno;
Knösel, Thomas;
Brüdgam, Denise;
Kircher, Malte;
Pfob, Christian H.;
Bundschuh, Ralph A.;
Rinscheid, Andreas;
Nittbaur, Bernd;
Wienand, Georgine;
Schottelius, Margret;
Reincke, Martin;
Lapa, Constantin;
Dierks, Alexander

Publication type:

Article

SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 988, doi. 10.2967/jnumed.123.267124

By:

Kircher, Malte;
Amerein, Adriana;
Augustin, Mareike;
Reitsam, Nic G.;
Enke, Johanna S.;
Patt, Marianne;
Wienand, Georgine;
Bundschuh, Ralph A.;
Pfob, Christian H.;
Lapa, Constantin;
Dierks, Alexander

Publication type:

Article

Stroma AReactive Invasion Front Areas (SARIFA) and the tumour immune microenvironment in colorectal cancer.

Published in:

2025

By:

Reitsam, Nic G.;
Märkl, Bruno

Publication type:

Letter

Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 457, doi. 10.1038/s41416-023-02515-4

By:

Grosser, Bianca;
Emmerson, Jake;
Reitsam, Nic G.;
Cunningham, David;
Nankivell, Matthew;
Langley, Ruth E.;
Allum, William H.;
Trepel, Martin;
Märkl, Bruno;
Grabsch, Heike I.

Publication type:

Article

Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response.

Published in:

Gastric Cancer, 2024, v. 27, n. 1, p. 72, doi. 10.1007/s10120-023-01436-8

By:

Grosser, Bianca;
Heyer, Christian M.;
Austgen, Johannes;
Sipos, Eva;
Reitsam, Nic G.;
Hauser, Andreas;
VanSchoiack, Alison;
Kroeppler, David;
Vlasenko, Dmytro;
Probst, Andreas;
Novotny, Alexander;
Weichert, Wilko;
Keller, Gisela;
Schlesner, Matthias;
Märkl, Bruno

Publication type:

Article

The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients.

Published in:

Cancer & Metabolism, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40170-024-00349-z

By:

Offermans, Kelly;
Reitsam, Nic G.;
Simons, Colinda C. J. M.;
Grosser, Bianca;
Zimmermann, Jessica;
Grabsch, Heike I.;
Märkl, Bruno;
van den Brandt, Piet A.

Publication type:

Article

Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA).

Published in:

Cancers, 2023, v. 15, n. 3, p. 994, doi. 10.3390/cancers15030994

By:

Reitsam, Nic G.;
Märkl, Bruno;
Dintner, Sebastian;
Sipos, Eva;
Grochowski, Przemyslaw;
Grosser, Bianca;
Sommer, Florian;
Eser, Stefan;
Nerlinger, Pia;
Jordan, Frank;
Rank, Andreas;
Löhr, Phillip;
Waidhauser, Johanna

Publication type:

Article

The SARIFA biomarker in the context of basic research of lipid-driven cancers.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00662-2

By:

Märkl, Bruno;
Reitsam, Nic G.;
Grochowski, Przemyslaw;
Waidhauser, Johanna;
Grosser, Bianca

Publication type:

Article

The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12519-9

By:

Grochowski, Przemyslaw;
Grosser, Bianca;
Sommer, Florian;
Probst, Andreas;
Waidhauser, Johanna;
Schenkirsch, Gerhard;
Reitsam, Nic G.;
Märkl, Bruno

Publication type:

Article

SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-023-11771-9

By:

Enke, Johanna S.;
Groß, Matthias;
Grosser, Bianca;
Sipos, Eva;
Steinestel, Julie;
Löhr, Phillip;
Waidhauser, Johanna;
Lapa, Constantin;
Märkl, Bruno;
Reitsam, Nic G.

Publication type:

Article

Works by Reitsam, Nic G.

C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy of Multiple Myeloma Using [<sup>99m</sup>Tc]Tc-PentixaTec.

Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid Carcinoma.

SARIFA – ein neuer entitätenübergreifender Biomarker.

Granulomatous dermatitis: a rare pitfall in lymphoma staging with [<sup>18</sup>F]FDG-PET/CT.

Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma.

Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy.

C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study.

SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma.

Stroma AReactive Invasion Front Areas (SARIFA) and the tumour immune microenvironment in colorectal cancer.

Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.

Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response.

The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients.

Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA).

The SARIFA biomarker in the context of basic research of lipid-driven cancers.

The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma.

SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.